Skip to main content
CURE logo
CURE
(NYSEARCA)
Direxion Daily Healthcare Bull 3X ETF
$136.48-- (--)
Loading... - Market loading

CURE ETF: Direxion Daily Healthcare Bull 3X ETF - Price, Holdings & Analysis

Direxion Daily Healthcare Bull 3X ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$135.85 - $138.78
52-Week High$150.00
52-Week Low$74.34
Open$136.47
Volume69.62K
Average Volume (3M)68.78K
Assets (AUM)174.96M
Expense Ratio0.94%
Total Holdings72
Inception DateJun 15, 2011
1 Day Change-3.31%
1 Month Change12.17%
6 Month Change28.11%
YTD Change20.80%
1 Year Change67.60%
52-Week Change67.60%
5 Year Change2.80%
10 Year Change319.94%
50-Day MA$125.77
200-Day MA$108.66
RSI53.75
Stochastic %K29.44
Stochastic %D51.62
Annual Dividend$1.91
Dividend Yield1.40%
Last Dividend Ex-DateSep 30, 2026
Dividend Growth YoY73.70%
Years Dividend Growth1

Frequently Asked Questions About Direxion Daily Healthcare Bull 3X ETF

What is the current price of CURE?

The latest CURE price is $136.48. The 52-week range is $74.34–$150.00. CURE has returned 67.6% over the past 52 weeks.

What is the expense ratio for CURE?

CURE's annual expense ratio is 0.94%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does CURE pay dividends?

Yes, CURE pays a 1.40% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.

What are the top holdings of CURE?

CURE's largest holdings are Eli Lilly and Company (11.0%), Johnson & Johnson (7.2%), AbbVie Inc (5.1%) (combined weight: 23.4%). The fund holds 72 total positions. View the complete portfolio breakdown in the Holdings section.

How does CURE compare to similar ETFs?

Compare CURE (0.94% expense ratio, $175M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.